Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
1 clinical trials · Condition
◉ Watch Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
| Record | Firm | Date |
|---|---|---|
| Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02207530) | AstraZeneca | 2014-10-23 |
Track Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck automatically
Every clearance here is in the API, with alerts when new ones post.